- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06686199
Potato Diet Intervention Study in a College Population
The goal of this study is to investigate the effects of a potato-based diet intervention on Chinese university students. Employing a randomized controlled double-blind trial design, the intervention will span 8 weeks. The primary objectives include:
- Examining the impact of the potato-based diet intervention on the overall glucose and lipid metabolism levels of university students;
- Exploring the interactions between the potato-based diet intervention and individual metabolic profiles and glucose-lipid metabolic pathways;
- Analyzing the association between the potato-based diet intervention and gut health through gut microbiota analysis.
Participants will undergo either the potato-based diet intervention or the control group treatment. Changes in waist circumference, blood pressure, blood glucose, and blood lipid levels will be observed to assess the effects of the potato-based diet on university students' health. Additionally, alterations in metabolic profiles and glucose-lipid metabolic pathways will be analyzed, along with gut microbiota analysis, to investigate the relationship between the potato-based diet and gut health.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study aims to recruit young adults aged 18-35 from university populations who meet the criteria and are willing to participate. After screening based on baseline information, eligible volunteers will be randomly assigned to two groups: an intervention group and a control group. The intervention group will consume fried potatoes, while the control group will consume steamed potatoes, at a daily dose of 135g, 4-5 times a week, for an 8-week dietary intervention period.
- The effects of potato-based dietary intervention on the metabolic profiles of glucose and lipids in the human body will be assessed. General indicators such as height, weight, blood pressure, waist circumference, and hip circumference will be measured at baseline and at the intervention endpoint for all participants. Fasting blood samples will be collected to measure four lipid parameters (TG, TC, LDL-C, HDL-C), fasting blood glucose, fasting insulin, glycosylated hemoglobin levels, and serum C-peptide levels. Changes and differences in glucose and lipid metabolism indicators among groups will be observed.
- The role of potato-based dietary intervention on the blood metabolic profiles, gut microbiota composition, and inflammatory response in university student populations will be investigated. Blood and stool samples will be collected to study the effects of potato-based dietary intervention on metabolic markers of glucose and lipids in biological samples and the gut microbiota composition in fecal samples. The analysis will focus on its effects on serum inflammatory factors by influencing glucose and lipid metabolism pathways and gut microbiota composition, as well as inflammatory signaling pathways, elucidating the mechanisms through which it modulates glucose and lipid metabolism.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yu Zhang
- Phone Number: 86-0571-88982211
- Email: yzhang@zju.edu.cn
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- University students at school
Exclusion Criteria:
- Smoking (≥1 cigarette/week);
- heavy alcohol consumption (>224 g/week for men and >168 g/week for women);
- diabetes, heart disease, stroke, high blood pressure, liver dysfunction, kidney dysfunction, or gastrointestinal disorders;
- taking dietary supplements (e.g., vitamins, minerals, probiotics, or prebiotics);
- taking medications (e.g., aspirin, statin, or antihypertensive medications);
- within the past 3 months taken antibiotics;
- had surgery in the past 3 months;
- participated in other clinical studies in the past 3 months;
- preference for fried and baked foods.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
|
135 g per day 4-5 times per week for 8 weeks
|
|
Placebo Comparator: Control group
|
135 g per day 4-5 times per week for 8 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in body weight from baseline
Time Frame: Time Frame: 2 months
|
The investigators will measure body weight before and after treatment.
|
Time Frame: 2 months
|
|
Change in blood glucose from baseline
Time Frame: Time Frame: 2 months
|
The investigators will measure fasting plasma glucose levels in blood samples before and after treatment.
|
Time Frame: 2 months
|
|
Change in triglycerides from baseline
Time Frame: 2 month
|
The investigators will measure Triglyceride levels in blood samples before and after treatment.
|
2 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in lipid indicators from baseline
Time Frame: 2 month
|
The investigators will measure total cholesterol, LDL-C, and HDL-C levels in blood samples before and after treatment.
|
2 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCT_ Potato Meal
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolism and Nutrition Disorder
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedOrthopedic Disorder | Metabolism and Nutrition DisorderItaly
-
Shandong Provincial HospitalRecruitingMetabolism and Nutrition Disorder | Rhythm Nodal | Metabolism Disorder, LipidChina
-
Yu ZhangNot yet recruitingMetabolism and Nutrition Disorder
-
Pennington Biomedical Research CenterCompletedMetabolism and Nutrition DisorderUnited States
-
Ospedale San DonatoUniversity of MilanCompletedMetabolism and Nutrition Disorder
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompleted
-
Maastricht UniversityCompletedMetabolic Disturbance | Metabolism and Nutrition DisorderNetherlands
-
Nanjing Medical UniversityCompletedNutrition | Metabolism DisorderChina
-
University of Kansas Medical CenterRecruitingResting Metabolic Rate | Post Operative Nutrition | Metabolism; Disorder, PostproceduralUnited States
-
Indiana UniversityAmerican Society for Parenteral and Enteral NutritionTerminatedMetabolism and Nutrition DisorderUnited States
Clinical Trials on steamed potato
-
Anne Birgitte RabenCompleted
-
Clinical Nutrition Research Center, Illinois Institute...CompletedPremenopausal Women | Overweight and Obese WomenUnited States
-
Penn State UniversityAlliance for Potato Research and EducationEnrolling by invitation
-
Guelph Food Research CentreNutrasource Pharmaceutical and Nutraceutical Services, Inc.Completed
-
University of ManitobaCompletedChronic Kidney DiseasesCanada
-
Ohio State UniversityAlliance for Potato Research and EducationCompletedCardiovascular Diseases | Endotoxemia | Endothelial Dysfunction | Postprandial Hyperglycemia | Gut HealthUnited States
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Mayo ClinicRecruitingHepatic Encephalopathy | CirrhosisUnited States
-
Maastricht University Medical CenterRecruitingGlucose Metabolism | Lipid MetabolismNetherlands
-
University of Alabama at BirminghamIndiana University; Alliance for Potato Research and EducationCompleted